|Title:||Dipeptidyl peptidase 4 inhibitor use is associated with a lower risk of incident acute kidney injury in patients with diabetes||Authors:||CHIA-TER CHAO
|Keywords:||acute kidney injury; chronic kidney disease; diabetes mellitus; dialysis-requiring acute kidney injury; dipeptidyl peptidase 4 inhibitor||Issue Date:||8-Aug-2017||Publisher:||IMPACT JOURNALS LLC||Source:||Oncotarget||Abstract:||
Dipeptidyl peptidase 4 inhibitor (DPP4i) use potentially slows the progression of diabetic kidney disease, but its effects on the risk of acute kidney injury (AKI) are unclear. We aimed to assess the association between DPP4i use and incident AKI episodes from a nationally representative cohort in Taiwan.
|Appears in Collections:||醫學院附設醫院 (臺大醫院)|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.